Abstract
Down syndrome screening can be particularly effective when both first and second trimester tests are performed. However, the counseling of women who have received sequential first and second trimester screening can be problematic. We evaluated an approximation where the post-test risk from the first trimester screening is used as the new a priori risk for the second trimester screening. The approximation disregards between-trimester test correlations. The Down syndrome detection rate based on the approximation (90.2%) would be close to that obtained when all correlations were considered (90.8%) but the false positive rate would be 26% higher (3.9% versus 3.1%, respectively). For any particular woman, the use of the approximation could result in highly inaccurate risks. We conclude that the correlations that exist between first and second trimester screening tests preclude the use of second trimester risks derived from the direct product of separate first and second trimester screening. Counseling issues in the delivery of sequential screening are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benn, P. A., Fang, M., Egan, J. F. X., Horne, D., & Collins, R. (2003). Incorporation of Inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol, 10, 451–454.
Benn, P., Wright, D., & Cuckle, D. (2005). Practical strategies for contingent sequential screening for Down's syndrome. Prenat Diagn, 25, 645–652.
Bindra, A., Heath, V., Liao, A., Spencer, K., & Nicolaides, K. H. (2002). One-stop clinic for assessment for risk for trisomy 21 at 11–14 weeks: A prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol, 20, 219–225.
Bray, I., Wright, D. E., Davies, C., & Hook, E. B. (1998). Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn, 18, 9–20.
Chen, J., Heffley, D., Beazoglou, T., & Benn, P. A. (2000). Utilization of amniocentesis by women screen-positive for Down syndrome by the second trimester triple test. Community Genet, 3, 24–30.
Copel, J. A., & Bahado-Singh, R. O. (1990). Prenatal screening for Down's syndrome—a search for family's values. N Engl J Med, 341, 521–522.
Malone, F. (2005). Letter to the Editor: Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol, 105, 438.
National Center for Health Statistics. (2002). Vital statistics of the United States, 2000. Natality Data Set. Hyattsville, MD. CD ROM, Series 21:14, Hyattsville, MD.
Platt, L. D., Greene, N., Johnson, A., Zachary, J., Thom, E., Krantz, D., et al. (2004). Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol, 104, 661–666.
Wald, N. J., Cuckle, H. S., Densem, J. W., Nanchahal, K., Royston, P., Chard, T., et al. (1988). Maternal serum screening for Down's syndrome in early pregnancy. BMJ, 297, 883–887.
Wald, N., Watt, H. C., & Hackshaw, A. K. (1999). Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med, 341, 461–467.
Wald, N. (2000). Down's syndrome. In N. Wald & I. Leck (Eds.), Antenatal and neonatal screening, 2nd ed. (pp. 83–115). Oxford, UK: Oxford University Press.
Wald, N. J., Huttley, W. J., & Hackshaw, A. K. (2003a). Antenatal screening for Down's syndrome with the quadruple test. Lancet, 361, 835–836.
Wald, N. J., Rodeck, C., Hackshaw, A. K., Walters, J., Chitty, L., & Mackinson, A. M. (2003b). First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen, 10, 56–104.
Wald, N., Rodeck, C., Rudnicka, A., & Hackshaw, A. (2004). Letter to the editor. Nuchal translucency and gestational age. Prenat Diagn, 24, 150–151.
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., et al. (2003). First trimester screening for trisomies 21 and 18. N Engl J Med, 349, 1405–1413.
Wright, D., Bradbury, I., Benn, P., Cuckle, H., & Ritchie, K. (2004). Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn, 24, 762–766.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benn, P., Donnenfeld, A.E. Sequential Down Syndrome Screening: The Importance of First and Second Trimester Test Correlations when Calculating Risk. J Genet Counsel 14, 409–413 (2005). https://doi.org/10.1007/s10897-005-6390-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-005-6390-7